These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12110028)

  • 1. Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients.
    van Tellingen A; Grooteman MP; Schoorl M; Bartels PC; Schoorl M; van der Ploeg T; ter Wee PM; Nubé MJ
    Kidney Int; 2002 Aug; 62(2):632-8. PubMed ID: 12110028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
    van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis.
    Schouten WE; Grooteman MP; van Houte AJ; Schoorl M; van Limbeek J; Nubé MJ
    Nephrol Dial Transplant; 2000 Mar; 15(3):379-84. PubMed ID: 10692524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.
    Van Tellingen A; Grooteman MP; Bartels PC; Van Limbeek J; Van Guldener C; Wee PM; Nubé MJ
    Kidney Int; 2001 Jan; 59(1):342-7. PubMed ID: 11135089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
    Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
    Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
    Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
    Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide concentrations during superflux dialysis using unfiltered bicarbonate dialysate.
    van Tellingen A; Grooteman MP; Pronk R; van Loon J; Vervloet MG; ter Wee PM; Nubé MJ
    ASAIO J; 2002; 48(4):383-8. PubMed ID: 12141468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
    Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
    Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Ghiadoni L; Filippi C; Cristofani R; Panicucci E; Migliori M; Sidoti A; Biagioli M; Boracelli D; Barsotti G; Tetta C
    Nephron Clin Pract; 2006; 102(2):c51-8. PubMed ID: 16224196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
    Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of different haemodialysis modalities on AGE peptide levels: intradialytic versus long-term results.
    van Tellingen A; Schalkwijk CG; Teerlink T; Barto R; Grooteman MP; van der Ploeg T; ter Wee PM; Nubé MJ
    Nephron Clin Pract; 2005; 100(1):c1-7. PubMed ID: 15731564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.